TRPV3 and glioblastoma: Overexpression of TRPV3 correlates with tumor progression and short OS in non-small cell lung carcinoma (NSCLC) (p = 0.020) [6]; and loss or reduction of TRPML1 mRNA expression correlates with short survival in glioblastoma (GBM) patients (p < 0.0298) [7].